TGFB1 and neoplasm: For example, induction of EMT in a non-tumorigenic breast cell line by treatment with TGF-β1 leads to acquisition of the CD44high/CD24low cell surface phenotype typical of breast CSCs that have tumour-initiating and tumour-sphere forming abilities [16].